Paushak Limited (PAUSHAKLTD)

Loading page…

Paushak Limited (PAUSHAKLTD) · mywealthgrid

About

Paushak Limited manufactures specialty chemicals for industrial applications. With market cap ₹1,829.78 Cr and recent quarterly revenues of ₹50–84 Cr, it is a mid-sized player in India's specialty chemicals sector. Operating margins consistently run 23–31%, indicating competitive positioning in higher-margin chemical niches.

Face value: ₹5

Market cap

₹1,606 Cr

P/E

35.9×

P/B

3.3×

Dividend yield

3.5%

ROE

8.2%

ROCE

9.2%

Debt / equity

0.16

OPM

27.8%

EPS (TTM)

₹18.2

Book value

₹199.2

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

High valuation relative to returns: PE 40.85 against ROE 8.22% and -1.25% one-year return; verify if growth outlook justifies the premium.
EPS dilution: earnings per share fell 83% from ₹35.73 (Mar 2021) to ₹6.13 (Jun 2026) following stock split and bonus in Oct 2025; confirm if further dilution is planned.
Low institutional participation: FII 0% and DII 0.07% suggest weak analyst coverage or institutional confidence; verify research participation and fund demand.
ROE–margin gap: operating margins of 27.81% contrast with ROE of 8.22%; verify whether capital is underutilized, invested in low-return segments, or held as excess cash/receivables.

Generated analysis · source review pending

Growth drivers

Jun 2026 revenue of ₹83.55 Cr is 71% above Dec 2025's ₹48.8 Cr and the strongest quarter in the dataset; verify if growth rate is sustainable or cyclical.
Operating margins of 30.7% (Jun 2026) and 30.34% (Mar 2026) indicate cost control; verify whether these reflect structural advantages or temporary pricing conditions.
Low debt level with D/E ratio of 0.16 enables future capex without dilution; verify management's plans to invest in specialty chemical capacity expansion.
Six-year revenue growth from ₹32.24 Cr (Jun 2020) to ₹83.55 Cr (Jun 2026) reflects multi-year scale-up; verify demand drivers across pharma, agro-chemical, and specialty polymer segments.

Generated analysis · source review pending

556 historical price candles were omitted because the exchange source has not been verified.

₹650.3-2.7%1Y

Quick read

rule-based

Pros

+Healthy operating margin of 27.8%
+Comfortable interest coverage of 46.4×
+Dividend yield of 3.5%
+High promoter holding of 67.3% with no pledge

Cons

−Modest revenue growth of 9.2% a year over the last 5 years

Research score

Structured signal from quality, growth, valuation and momentum.

52/100

Business quality: 59
Growth: 51
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	77	70	105	140	138	141	150	212	206	211	219
COGS	—	—	-37	-54	-45	34	30	46	45	44	46
Gross profit	—	—	—	—	—	107	120	166	161	167	173
	64	61	113	153	141	56	66	91	97	107	112
	13	9	29	40	43	50	54	75	65	60	61
OPM %	16.9%	13.1%	27.9%	28.8%	31%	35.8%	36.1%	35.4%	31.3%	28.3%	27.8%
Depreciation	—	—	3	4	4	5	9	13	14	15	21
Interest	0	0	0	0	0	0	0	0	0	0	1
	3	5	3	3	5	6	5	11	20	14	12
Profit before tax	17	14	—	49	45	52	50	72	71	59	50
Tax	4	3	7	10	10	14	13	18	17	9	11
Tax %	25.2%	21.8%	—	20.5%	23.1%	27.7%	25.2%	25.2%	23.4%	16%	22%
	12	11	21	39	35	37	38	54	54	49	39
PAT margin %	16.1%	15.6%	20.5%	27.9%	25.3%	26.5%	25.1%	25.4%	26.4%	23.4%	18%
EPS (₹)	38.8	34.4	66.9	125.7	113.3	121	122	175.2	176.4	160.2	16
EPS adjusted (₹)	—	—	—	—	14.2	15.1	15.3	21.9	22.1	20	16
	7.7%	8.7%	4.5%	4%	5.3%	5%	9.8%	10%	11.3%	12.5%	15.7%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	3	3	3	3	3	3	12
Reserves	—	269	302	351	405	462	479
	—	0	0	0	0	25	77
	—	57	61	61	73	81	92
Total equity & liabilities	—	329	367	415	481	572	660
	41	51	147	149	152	141	377
CWIP	—	68	8	7	29	190	26
Investments	—	154	151	182	223	139	150
	—	56	61	78	77	102	107
Total assets	—	329	367	415	481	572	660

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	75.8%	80.2%	78.3%	78.3%	79.1%	79.1%
EBITDA margin %	28.8%	31%	35.8%	36.1%	35.4%	31.3%	28.3%	27.8%
EBIT margin %	26%	27.9%	32.3%	30.1%	29.1%	24.6%	21.2%	18%
PAT margin %	27.9%	25.3%	26.5%	25.1%	25.4%	26.4%	23.4%	18%
Working capital
Receivable days	—	—	85	97	90	90	94	92
Inventory days	—	—	148	233	180	177	179	292
Payable days	—	—	118	227	122	130	167	245
NWC days	—	—	115	103	149	137	107	139
Leverage
Current ratio	—	—	3.49	3.83	6.6	8.3	2.24	2.01
Debt to EBITDA	—	—	0	0	0	0	0.42	1.27
Debt to equity	—	—	0	0	0	0	0.05	0.16
Interest coverage	299.7	614.6	1,032.6	839	228.5	474.3	420.8	46.4
Asset turnover	—	—	0.43	0.41	0.51	0.43	0.37	0.33
Return ratios
Return on assets %	—	—	11.3%	10.3%	13%	11.3%	8.6%	6%
Return on capital employed %	—	—	17.1%	15.7%	19.4%	16.8%	12%	9.2%
Return on equity %	—	—	13.7%	12.3%	15.3%	13.3%	10.6%	8%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	66.97%	66.97%	66.97%	66.97%	66.97%	66.97%	67.13%	67.13%	67.28%	67.28%	67.28%	67.28%
FII	0.02%	0.02%	0.02%	0%	0%	0%	0.01%	0%	0%	0%	0%	0%
	0%	0.11%	0.2%	0.29%	0.34%	0.4%	0.53%	0.53%	0.71%	0.67%	0.25%	0.07%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	33.01%	32.9%	32.81%	32.74%	32.69%	32.63%	32.33%	32.34%	32.01%	32.05%	32.47%	32.65%
No. of shareholders	—	—	—	—	—	—	—	—	22,013	21,737	21,419	21,399

Promoter holding up 0.31 percentage points since Sep 2023.

Mr. Chirayu Ramanbhai AminNon-Executive - Non Independent Director-Chairperson related to Promoter
Mr. Udit Chirayu AminNon-Executive - Non Independent Director
Mrs. Roopa Bharat PatelNon-Executive - Independent Director
Mr. Tushar Arvind ShahNon-Executive - Independent Director
Mr. Tanuj Manubhai PatelNon-Executive - Independent Director
Mr. Jain ParkashExecutive Director
Ms. Kirti ShahChief Financial Officer
Mr. Sagar GandhiCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Paushak Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

17 announcementsExport CSV

28 Sept 2026, 6:17 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

12 Aug 2026, 6:47 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

31 Jul 2026, 5:32 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

30 Jul 2026, 9:45 pmAGM/EGM

Proceedings Of The 53Rd Annual General Meeting Held On 30Th July, 2026

AGM PDF

30 Jul 2026, 9:41 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

30 Jul 2026, 9:21 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

30 Jul 2026, 4:26 pmResult

Unaudited Financial Results Of The Company For The Quarter Ended On 30Th June, 2026

Financial Results PDF

30 Jul 2026, 4:22 pmBoard Meeting

Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting PDF

Date	Category	Subject	Filing
28 Sept 2026, 6:17 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
12 Aug 2026, 6:47 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	75.8%	80.2%	78.3%	78.3%	79.1%	79.1%
EBITDA margin %	28.8%	31%	35.8%	36.1%	35.4%	31.3%	28.3%	27.8%
EBIT margin %	26%	27.9%	32.3%	30.1%	29.1%	24.6%	21.2%	18%
PAT margin %	27.9%	25.3%	26.5%	25.1%	25.4%	26.4%	23.4%	18%
Working capital
Receivable days	—	—	85	97	90	90	94	92
Inventory days	—	—	148	233	180	177	179	292
Payable days	—	—	118	227	122	130	167	245
NWC days	—	—	115	103	149	137	107	139
Leverage
Current ratio	—	—	3.49	3.83	6.6	8.3	2.24	2.01
Debt to EBITDA	—	—	0	0	0	0	0.42	1.27
Debt to equity	—	—	0	0	0	0	0.05	0.16
Interest coverage	299.7	614.6	1,032.6	839	228.5	474.3	420.8	46.4
Asset turnover	—	—	0.43	0.41	0.51	0.43	0.37	0.33
Return ratios
Return on assets %	—	—	11.3%	10.3%	13%	11.3%	8.6%	6%
Return on capital employed %	—	—	17.1%	15.7%	19.4%	16.8%	12%	9.2%
Return on equity %	—	—	13.7%	12.3%	15.3%	13.3%	10.6%	8%

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	30	44	43	56	38	54
	-29	-42	-38	-50	-57	-95
	-2	-2	-4	-5	19	42
Net cash flow	-1	-0	0	0	-1	0
Free cash flow	-26	-4	26	17	-123	-34
CFO / Operating profit %	59.1%	81.1%	56.8%	86.8%	63%	88.3%

Paushak Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Credit ratings

18

1

1

Compounded sales growth

Compounded profit growth

Return on equity

Paushak Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Ratio timeline

Quarterly record

Board and management

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Credit ratings

Dividends18

Board meetings1

Stock splits1

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

18

1

1